Vibe Reports 2023 Second Quarter Financial Results
Vibe Reports 2023 Second Quarter Financial Results
Sacramento, California--(Newsfile Corp. - August 29, 2023) - Vibe Growth Corporation (CSE: VIBE) (OTCQX: VIBEF) (the "Company" or "Vibe"), a vertically integrated California cannabis enterprise, is pleased to announce its financial results for the three and six month periods ending June 30, 2023. All financial information is provided in U.S. dollars unless otherwise indicated. The Consolidated Financial Statements and Management Discussion and Analysis ("MD&A") for the three and six months ended June 30, 2023, are available on the Company's SEDAR+ profile at and Vibe's website at .
加利福尼亞州薩克拉門託-(Newsfile Corp.-2023年8月29日)-Vibe Growth Corporation(CSE：氛圍)(OTCQX：VIBEF)(“公司“或”氛圍)，一家垂直整合的加州大麻企業，很高興地公佈了截至2023年6月30日的三個月和六個月的財務業績。除非另有說明，所有財務資訊都是以美元提供的。截至2023年6月30日的三個月和六個月的綜合財務報表和管理層討論與分析(“MD&A”)可在公司的SEDAR+簡介和Vibe的網站上查閱。
Financial Highlights
財務亮點
The Company's key financial results for the three and six months ended June 30, 2023, and 2022, are as follows:
該公司截至2023年6月30日和2022年6月30日的三個月和六個月的主要財務業績如下：
| U.S. Dollars | For the three months ended June 30, 2023 |
For the three months ended June 30, 2022 |
For the six months ended June 30, 2023 |
For the six months ended June 30, 2022 |
||||||||
| Total revenue(a) | $ | 3,690,295 | $ | 5,728,286 | $ | 7,694,251 | $ | 11,399,262 | ||||
| Gross margin | $ | 1,312,675 | $ | 2,336,296 | $ | 2,791,352 | $ | 4,295,727 | ||||
| Net loss | $ | (1,397,542 | ) | $ | (654,511 | ) | $ | (2,546,113 | ) | $ | (1,644,979 | ) |
| Adjusted funds flow(b) | $ | (1,012,428 | ) | $ | (224,203 | ) | $ | (1,755,445 | ) | $ | (596,338 | ) |
| EBITDA(a) | $ | (641,893 | ) | $ | 366,551 | $ | (1,017,164 | ) | $ | 79,146 | ||
| Adjusted EBITDA(a) | $ | (557,056 | ) | $ | 428,041 | $ | (905,524 | ) | $ | 384,992 |
| 美元 | 對於三個人來說 截至的月份 2023年6月30日 |
對於三個人來說 截至的月份 2022年6月30日 |
為六個人 截至的月份 2023年6月30日 |
為六個人 截至的月份 2022年6月30日 |
||||||||
| 總收入(A) | $ | 3690,295 | $ | 5728286 | $ | 7694,251 | $ | 11,399,262 | ||||
| 毛利率 | $ | 1312,675 | $ | 2336,296 | $ | 2791,352 | $ | 4,295,727 | ||||
| 淨虧損 | $ | (1,397,542 | ) | $ | (654,511 | ) | $ | (2546,113) | ) | $ | (1,644979 | ) |
| 調整後的資金流動(B) | $ | (1012,428 | ) | $ | (224,203 | ) | $ | (1,755,445 | ) | $ | (596,338 | ) |
| EBITDA(A) | $ | (641,893 | ) | $ | 366,551 | $ | (1017,164) | ) | $ | 79,146 | ||
| 調整後的EBITDA(A) | $ | (557,056 | ) | $ | 428,041 | $ | (905524 | ) | $ | 384,992 |
Special Note Regarding non-GAAP Financial Measures
關於非公認會計準則財務指標的特別說明
(a) This is a non-GAAP measure. Readers are cautioned that the amounts presented do not have standardized meanings prescribed by IFRS. See the discussion of non-IFRS Measures in the MD&A for reconciliation to measures reported in the Company's consolidated financial statements.
(b) Excludes changes in the fair value of biological assets.
(A)這是一項非公認會計準則的措施。請讀者注意，列報的金額沒有國際財務報告準則所規定的標準含義。請參閱MD&A中關於非IFRS措施的討論，以與公司合併財務報表中報告的措施進行對賬。
(B)不包括生物資產公允價值的變動。
2023 Second Quarter Highlights
2023年第二季度亮點
Cash position as of June 30, 2023, was $3.19 million.
Dispensary Sales: Dispensary sales were $3.69 million for the second quarter of 2023, compared to $4.00 million in the first quarter of 2023, representing a 7.75% decline.
Average Basket Size: The average dispensary basket size, net of taxes, for the three-month period ended June 30, 2023, was $41.18, compared to $40.49 in the first quarter of 2023 period.
EBITDA: In the three-month period ended June 30, 2023, the adjusted EBITDA loss was $557,056 compared to the fourth quarter of 2022, which was $2,706,964, representing an improvement of $2,149,908.
現金截至2023年6月30日的頭寸為319萬美元。
藥房銷售： 2023年第二季度，藥房銷售額為369萬美元，而2023年第一季度為400萬美元，下降了7.75%。
平均籃子大小：在截至2023年6月30日的三個月裡，扣除稅收的平均藥房籃子大小為41.18美元，而2023年第一季度為40.49美元。
EBITDA： 在截至2023年6月30日的三個月期間，調整後的EBITDA虧損為557,056美元，與2022年第四季度的2,706,964美元相比，改善了2,149,908美元。
Vibe CEO Mark Waldron commented, "In the second quarter, we laid the groundwork for centralized purchasing and internal distribution, leading to improvements to Vibe's gross margins. Vibe should be positioned toward improved profitability in the second half of 2023 by launching new Hype products, increased marketing efforts, and continued cost control measures."
Vibe首席執行官Mark Waldron評論說：“在第二季度，我們為集中採購和內部分銷奠定了基礎，從而提高了Vibe的毛利率。Vibe應該通過推出新的炒作產品、加大營銷力度和持續的成本控制措施，在2023年下半年提高盈利能力。”
About Vibe Growth Corporation
關於Vibe Growth公司
Vibe Growth Corporation and its cannabis retail brand, Vibe By California, is a trusted, vertically integrated California cannabis enterprise with retail dispensaries; cannabis greenhouse cultivation; premium indoor cultivation; commercial cannabis distribution; brand sales and marketing; e-commerce platform; home delivery; and Hype Cannabis Co. marijuana and Vibe CBD products. In California, Vibe is focused on maximizing shareholder value through accelerating organic growth, opportunistic acquisitions, distressed workouts, and new license applications. The Company operates retail and e-commerce under its iconic Vibe By California brand.
Vibe Growth Corporation及其大麻零售品牌Vibe by California是一家值得信賴的垂直整合的加州大麻企業，擁有零售藥房、大麻溫室種植、優質室內種植、商業大麻分銷、品牌銷售和營銷、電子商務平臺、送貨上門以及炒作大麻公司大麻和Vibe CBD產品。在加利福尼亞州，Vibe專注於通過加速有機增長、機會性收購、困境解決方案和新的許可證申請來實現股東價值最大化。該公司以其標誌性的Vibe by California品牌經營零售和電子商務。
To learn more about Vibe, please visit: .
要了解更多關於Vibe的資訊，請訪問：。
Cautionary Note Regarding Product & Forward-Looking Information
有關產品和前瞻性資訊的注意事項
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performances. The use of any of the words "anticipate," "could," "intend," "expect," "believe," "will," "projected," "estimated," and similar expressions or statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties' current belief or assumptions as to the outcome and timing of such future events, and maybe impacted as a result of general economic conditions. In this news release, forward-looking statements relate to, among other things, the Company's expectations of revenue, EBITDA profitability and adjusted funds flow, higher sales volumes, and the Company's retail operations. Actual future results may differ materially.
本新聞稿中包含的某些陳述屬於前瞻性資訊。這些陳述與未來的活動或未來的表演有關。使用“預期”、“可能”、“打算”、“預期”、“相信”、“將會”、“預計”、“估計”以及與非歷史事實有關的類似表述或陳述，旨在識別前瞻性資訊，並基於當事人目前對此類未來事件的結果和時機的信念或假設，可能會受到一般經濟狀況的影響。在本新聞稿中，前瞻性陳述涉及公司對收入的預期、EBITDA盈利能力和調整後的資金流、更高的銷售額以及公司的零售業務。未來的實際結果可能會有很大不同。
The forward-looking information contained in this release is made as of the date hereof, and the parties are not obligated to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties, and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein. Risk factors related to the Company are described in the Company's Management Discussion and Analysis, a copy of which is available under the Company's profile on SEDAR+.
本新聞稿中包含的前瞻性資訊是截至本文發佈之日的，除非適用的證券法要求，否則雙方沒有義務更新或修改任何前瞻性資訊，無論是由於新資訊、未來事件或其他原因。由於本文包含的風險、不確定性和假設，投資者不應過度依賴前瞻性資訊。上述陳述明確表示，本文中包含的任何前瞻性資訊都是合格的。與公司相關的風險因素在公司的管理討論和分析中進行了描述，其副本可在SEDAR+上的公司簡介下獲得。
This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any State securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. securities laws.
本新聞稿不構成在美國出售或邀請購買任何證券的要約。這些證券沒有也不會根據修訂後的《1933年美國證券法》(以下簡稱《美國證券法》)或任何州證券法進行登記，除非根據《美國證券法》和適用的州證券法登記或獲得此類登記豁免，否則不得在美國境內或向美國公民發行或出售證券。不得分發給美國新聞通訊社或在美國境內傳播。任何不遵守這一限制的行為都可能構成對美國證券法的違反。
Unlike in Canada, which has Federal legislation uniformly governing the cultivation, distribution, sale, and possession of medical cannabis under the Cannabis Act (Federal), readers are cautioned that in the U.S., cannabis is largely regulated at the State level. To the knowledge of Vibe Growth Corporation, there are, to date, a total of 33 states, plus the District of Columbia, that have legalized cannabis in some form. Notwithstanding the permissive regulatory environment of medical cannabis at the State level, cannabis continues to be categorized as a controlled substance under the Controlled Substances Act in the U.S., and as such, cannabis-related practices or activities, including, without limitation, the manufacture, importation, possession, use or distribution of cannabis are illegal under U.S. federal law. Strict compliance with state laws concerning cannabis will neither absolve Vibe of liability under the U.S. Federal law nor will it provide a defense to any Federal proceeding which may be brought against Vibe Growth Corporation. Any such proceedings brought against Vibe may adversely affect its operations and financial performance.
與加拿大不同的是，加拿大的聯盟立法根據《大麻法案》(Federal)統一管理醫用大麻的種植、分銷、銷售和擁有，讀者需要注意的是，在美國，大麻在很大程度上受到州一級的監管。據Vibe Growth Corporation瞭解，到目前為止，總共有33個州，加上哥倫比亞特區，以某種形式將大麻合法化。儘管在州一級對醫用大麻實行寬鬆的監管環境，但根據美國《管制物質法》，大麻仍被歸類為受控物質，因此，根據美國聯盟法律，與大麻有關的做法或活動，包括但不限於製造、進口、擁有、使用或分銷大麻，都是非法的。嚴格遵守有關大麻的州法律既不會免除Vibe在美國聯盟法律下的責任，也不會為可能對Vibe Growth Corporation提起的任何聯盟訴訟提供辯護。對Vibe提起的任何此類訴訟都可能對其運營和財務業績產生不利影響。
To view the source version of this press release, please visit
要查看本新聞稿的源版本，請訪問
譯文內容由第三人軟體翻譯。